Belize vs Saint Vincent and the Grenadines: Hypertension effective treatment coverage (controlled hypertension)
Belize
21.4%
in 2019
Saint Vincent and the Grenadines
20.5%
in 2019
Belize rank
76th
Saint Vincent and the Grenadines rank
79th
Hypertension effective treatment coverage (controlled hypertension) over time
- Belize
- Saint Vincent and the Grenadines
How they compare
Belize currently reports 21.4% against 20.5% in Saint Vincent and the Grenadines, a difference of 0.9%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Saint Vincent and the Grenadines ahead.
Belize ranks 76th and Saint Vincent and the Grenadines ranks 79th of 193 countries.
Across the 3 decades both report, Belize averaged higher in 1 and Saint Vincent and the Grenadines in 2.
Head to head by decade
| Decade | Belize | Saint Vincent and the Grenadines | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 6.9% | 7.3% | 0.4% | Saint Vincent and the Grenadines |
| 2000s | 12.9% | 13.3% | 0.4% | Saint Vincent and the Grenadines |
| 2010s | 19.5% | 19.1% | 0.4% | Belize |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hypertension effective treatment coverage (controlled hypertension), Belize or Saint Vincent and the Grenadines?
- Belize, at 21.4% against 20.5% in Saint Vincent and the Grenadines as of 2019.
- What is the difference in hypertension effective treatment coverage (controlled hypertension) between Belize and Saint Vincent and the Grenadines?
- 0.9%, with Belize ahead.
- How many years of comparable data are there for Belize and Saint Vincent and the Grenadines?
- 30 years are reported by both, from 1990 to 2019.
- How do Belize and Saint Vincent and the Grenadines rank globally for hypertension effective treatment coverage (controlled hypertension)?
- Belize ranks 76th and Saint Vincent and the Grenadines ranks 79th of 193 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hypertension effective treatment coverage (controlled hypertension )among adults aged 30-79, age-standardized (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.